100% Locally Owned, Independent and Free

100% Locally Owned, Independent and Free

German health officials have raised doubts about the effectiveness of the AstraZeneca vaccine

Do you have a news tip? Click here to send to our news team.

Supermarkets told to pass on savings at the checkout

Supermarkets have been put on notice to pass on savings when meat and food prices drop. When wholesale prices go down, the cost of items More

Weather bureau doing its best amid ‘chaos’, expert says

Australians are quick to complain when they are caught out by an unexpected shift in weather patterns and a shower turns into a deluge, More

Vehicles caught using more petrol in real-world tests

Early results from a $14 million program to test the real-world efficiency of cars on Australian roads has found more than half use more More

Almost a third of GPs plan to retire in next five years

Almost a third of GPs plan to retire in the next five years, prompting a call from their professional body to boost doctor numbers More

Boozy stowaway’s 400km journey under a truck

It seemed like a good idea at the time. However, a man who claimed to be from the Sunshine Coast is now regretting his boozy More

Caravan sellers on notice over dodgy pricing

The consumer watchdog has fired off a stern warning to caravan retailers over misleading customers on price. The mobile home retailing industry has already been More

There are fresh concerns about the vaccine that most Australians will receive after Germany advised against giving the AstraZeneca jab to people aged over 65.

Australia has ordered more than 50 million doses of the AstraZeneca vaccine and plans to distribute the drug within months.

The jab developed by Oxford University, which will be produced in the CSL factory in Melbourne, is the vaccine that most Australians will receive under the government’s rollout plan.

However Germany’s vaccine committee says there is not enough trial data available to support approving the jab for over 65s, although British regulators insist the drug is safe.

Australian authorities are still assessing the data before approving the AstraZeneca jab.

Home Affairs Minister Peter Dutton has called for calm as the Therapeutic Goods Administration goes through the process.

“People need to look at advice coming out of the TGA. The medical advice, the scientific advice in this country, is what we should heed,” Mr Dutton told Nine on Friday.

“We have the best scientists in the world.

“They have not rushed this process, they’ve looked at the efficacy of the vaccines, and we will make decisions to roll it out on that basis.”

Germany’s Standing Committee on Vaccination (STIKO) said there was “insufficient data” on the effectiveness of the vaccine for people in the over 65s category.

“Due to the small number of study participants in the age group ≥65 years, no conclusion can be made regarding efficacy and safety in the elderly,” the panel said in its recommendation to the German government.

“This vaccine is therefore currently recommended by STIKO only for persons aged 18-64 years.”

Doubts about the AstraZeneca jab add to concerns about whether Pfizer can keep up with global demand for its vaccine.

There are fears the combination of factors could put a dent in public confidence, which will be crucial to the vaccine rollout.

The Pfizer vaccine has already received TGA approval in Australia.

Treasurer Josh Frydenberg said that drug would now be rolled out without age restrictions.

Mr Frydenberg expects the TGA to reach a decision on the AstraZeneca vaccine by early March, if not sooner.

“They will take into account the German regulatory authorities and data as well as the British regulatory authorities thinking and data,” he told Sky News.

“The Germans have said they don’t have enough data to provide it to those over 65 whereas the UK regulatory authorities have reached a different decision.”

The government plans to roll out the imported Pfizer vaccine first in late February, followed by shipments of imported AstraZeneca jabs and then the Melbourne-made CSL product.

Meanwhile, Australia has extended its pause on the New Zealand travel bubble for another three days.

Two coronavirus cases across the Tasman have led to the extension of hotel quarantine for New Zealand arrivals until at least 2pm on Sunday.

Kiwi health authorities believe three local cases were transmitted at one quarantine facility, the Pullman Hotel in Auckland.

Twelve people who were at the hotel travelled to Sydney, with some going on to other states. They have since been contacted by health authorities.

The New Zealand government remains hopeful of the bubble being extended to allow Australians and Kiwis to move freely across the Tasman in both directions without quarantine by the end of March.

[scn_go_back_button] Return Home

Subscribe to SCN’s daily news email

This field is for validation purposes and should be left unchanged.